You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight
Statistics Canada released January retail sales for the country, with cannabis sales decreasing from the December levels, down 11.5% to C$400.7 million. December was revised higher to
Ispire Technology Announces Pricing of $12.3 Million Public Offering LOS ANGELES, March 22, 2024 /PRNewswire/ — Ispire Technology Inc. (“Ispire” or the “Company”) (NASDAQ: ISPR),
Among patients over 65 who received an allogeneic hematopoietic stem cell transplant (allo-HCT) for the treatment of acute myeloid leukemia (AML) between 2000 and 2021,
A recent study shows exercise is also beneficial and safe for older people with multiple chronic conditions or risk factors. Exercise can improve physical fitness
Women with a history of adverse pregnancy complications are at significantly higher risk of developing heart disease but can reduce their risk by maintaining optimal
A research consortium led by Nestlé Research in Switzerland and the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) made a
The revitalization of psychedelic substances for therapeutic applications has ignited significant interest in their potential as breakthrough treatments, driving a flurry of research and efforts
Aging may be less about specific “aging genes” and more about how long a gene is. Many of the changes associated with aging could be
Share this article Italfarmaco’s officr in Milan, Italy. The FDA’s decision follows positive results from the Phase III EPIDYS trial. Credit: Italfarmaco Italy-based pharma company